Prestige Consumer Healthcare (PBH) Net Cash Flow (2010 - 2025)

Prestige Consumer Healthcare's Net Cash Flow history runs 16 years deep, the most recent figure standing at -$57.0 million for Q4 2025.

• On a quarterly basis, Net Cash Flow fell 4142.91% year-over-year to -$57.0 million in Q4 2025; TTM through Dec 2025 was $10.3 million, a 189.88% increase from a year earlier, with the FY2025 full-year figure at $52.0 million, up 526.13% from the prior year.
• Net Cash Flow declined to -$57.0 million in Q4 2025 per PBH's latest filing, from -$20.4 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $131.6 million in Q2 2021 and bottomed at -$119.9 million in Q3 2021.
• The 5-year median for Net Cash Flow is $1.8 million (2023), against an average of $89700.0.
• Across the five-year window, Net Cash Flow surged 439.6% in 2021 and slumped 4142.91% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at -$21.6 million in 2021, then surged by 299.9% to $43.1 million in 2022, then plunged by 95.05% to $2.1 million in 2023, then slumped by 33.9% to $1.4 million in 2024, then slumped by 4142.91% to -$57.0 million in 2025.
• Per Business Quant, the three latest PBH Net Cash Flow figures stand at -$57.0 million (Q4 2025), -$20.4 million (Q3 2025), and $40.8 million (Q2 2025).